Magnetic resonance imaging fractal analysis of O(6)-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase wild-type glioblastoma. [PDF]
Xue C +10 more
europepmc +1 more source
Symptom management in isocitrate dehydrogenase mutant glioma. [PDF]
Walbert T +9 more
europepmc +1 more source
Survival Impact of Isocitrate Dehydrogenase (IDH)-Wildtype Histological Versus Molecular Glioblastoma: A Propensity Score-Matched Analysis. [PDF]
Patil N +6 more
europepmc +1 more source
The value of multi-parametric magnetic resonance imaging (MRI) radiomics in predicting isocitrate dehydrogenase (IDH) wildtype with telomerase reverse tranase (TERT) promoter mutation in glioma. [PDF]
Wang J, Qu D, Zhang H, Zhang H.
europepmc +1 more source
Venous thromboembolism incidence shortens survival in isocitrate dehydrogenase wild-type glioblastoma. [PDF]
Sloan AR +7 more
europepmc +1 more source
Prognostic Biomarkers in Isocitrate Dehydrogenase Wild-Type Glioblastoma: A Focus on B7-H3. [PDF]
Yüceer RO +5 more
europepmc +1 more source
Early seizure freedom with [<sup>18</sup>F]fluorodopa positron emission tomography response after isocitrate dehydrogenase inhibition with vorasidenib: First case report. [PDF]
Rudà R +5 more
europepmc +1 more source
Diagnostic performance of deep learning for predicting glioma isocitrate dehydrogenase and 1p/19q co-deletion in MRI: a systematic review and meta-analysis. [PDF]
Farahani S +5 more
europepmc +1 more source
Related searches:
Accurate and noninvasive detection of isocitrate dehydrogenase (IDH, including IDH1 and IDH2) status is clinically meaningful for molecular stratification of glioma, but remains challenging.
Hong Peng +6 more
semanticscholar +1 more source

